Eikon Therapeutics Statistics
NASDAQ: EIKNHealthcareBiotechnologyUSD
7.54+0.03 (+0.40%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Eikon Therapeutics by the numbers
Eikon Therapeutics has a market capitalization of $408.4 million based on 54.17M shares outstanding. With trailing EPS of $-8.51, Eikon Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.3% below its 50-day average and 30.2% below its 200-day average.
Average daily trading volume is 485.89K shares, or about $3.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EIKN valuation vs. peer median
| Metric | EIKN | Peer median | Difference |
|---|---|---|---|
| Market cap | $408.40M | $419.42M | -3% |
| Avg. volume | 485.89K | 603.01K | -19% |
Peer median across 8 companies: AVIR, ZURA, YDES, EDIT, RZLT, DMAC, KYTX, AGMB.
Valuation
- Market cap
- $408.40M
- EPS (TTM)
- $-8.51
- Shares outstanding
- 54.17M
Price and trading
- Previous close
- 7.51
- Open
- 7.32
- Day range
- 7.11 – 7.63
- 52-week range
- 7.02 – 17.40
- Beta
- —
- Volume
- 916.63K
- Average volume
- 485.89K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 408.40M
- Forward Pe
- -1.19
- Eps
- -8.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.40
- Week52 Low
- 7.02
- Avg Volume
- 485.89K
- Shares Outstanding
- 54.17M
- Ma50
- 9.70
- Ma200
- 10.80
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -56.67%
- Pct From52w Low
- 7.41%